Nephros Inc Revenue per Employee (NEPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nephros Inc   (NASDAQ: NEPH)
 

Nephros Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 58.55% in the second quarter 2026, year on year to cumulative value of $22 million, Nephros Inc 's revenue per employee grew on a trailing twelve months basis to $ 602,389. The productivity of Nephros Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 162 other companies have achieved higher revenue per employee. While Nephros Inc 's total ranking has deteriorated compared to the previous quarter from 1094 to 1486. Nephros Inc has 36 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEPH Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 58.55 % 20.2 % 51.08 % 24.33 % 30.32 %
Sales per Employee (TTM) $ 602,389 540,667 517,361 453,861 432,583
NEPH's Total Ranking # 1486 # 1094 # 1224 # 1509 # 1205
Seq. Revenue Change 20.51 % -26.15 % 72.69 % 3.16 % -8.64 %

NEPH Company Profile >> Back to NEPH Efficiency Comparisons >> Compare NEPH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 163
Overall Market # 1486

Revenue per Employee Statistics
High Average Low
$ 540,667 $ 235,964 $ 49,278
(Mar 31 2026)   (Sep 30 2015)



Financial Statements
Nephros Inc 's Revenue MRQ $ 6 Millions Visit NEPH's Income Statement
Nephros Inc 's Revenues TTM $ 22 Millions Visit NEPH's aggregate revenue growth
What are NEPH's Sales? Visit NEPH's Sales by Segment




Other Ratios
Nephros Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NEPH's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NEPH's Competitors
Revenue per Employee for NEPH's Suppliers
Revenue per Employee for NEPH's Customers

You may also want to know
NEPH's Sales Growth Rates NEPH's Pe Price to earnings ratio NEPH's Receivables Turnover Ratio NEPH's Stock Quote
NEPH's Net Income Growth Rates NEPH's Ps Price to Sales ratio NEPH's Sales per Employee NEPH's Asset Turnover Ratio
NEPH's Net Margin NEPH's Pb Price to Book ratio NEPH's Financial Strength Ratios NEPH's Dividend Payout Ratio
Date modified: 2026-08-12T20:31:27+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Vir Biotechnology Inc   826,231.61 $ 303.227  Million 367 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Adma Biologics Inc   789,697.06 $ 510.934  Million 647 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.